Evidence map›Paper›PMID 27660436›Full record

ArticleInternational journal of nanomedicine

Inhibitory effect of magnetic Fe

Meiyu Chen, Fei Xiong, Liang Ma, Hong Yao, Qinrong Wang, Lijun Wen, Qian Wang, Ning Gu, Suning Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. [Advances in the mouse models of myeloid leukemia].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Meiyu ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Fei XiongState Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing; Collaborative Innovation Center of Suzhou Nano Science and Technology, Suzhou, People's Republic of China.
Liang MaJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Hong YaoJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Qinrong WangJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Lijun WenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Qian WangJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
Ning GuState Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing; Collaborative Innovation Center of Suzhou Nano Science and Technology, Suzhou, People's Republic of China.
Suning ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Soochow University, Suzhou; Collaborative Innovation Center of Hematology, Soochow University, Suzhou.
First Affiliated Hospital of Soochow University · CNSoochow University · CNState Key Laboratory of Digital Medical Engineering

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homoharringtonine (HHT), a natural cephalotaxine alkaloid, has been used in the People's Republic of China for treatment of leukemia for >3 decades. Here, we employed magnetic Fe

Indexed as

HHTleukemiamagnetic Fe3O4 nanoparticlesmagnetic nanoparticles

Identifiers

PMID27660436
PMCPMC5019325
OpenAlexW2508223030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.